Dr Trevor Bachmeyer post

Audited February 28, 2026 · by PeptIQ

No Evidence

This set of claims about BPC-157 appears to be entirely unsupported by scientific literature. No PubMed studies were found to validate any of the specific claims made about the peptide's long-term effects or mechanisms of action.

Post captionshow

BPC 157 forever? (pay attention to this one) Comment “FOREVER” for research 2018 Sikiric: proved that low, long-term, consistent and daily…it creates a biology that prevents damage and disease from happening Want more? 2009 NIH: proved that long term it causes persistent improvements in tissue repair capacity and structural improvement across the entire system Over fifteen years of researc

Show full post caption

h… hundreds and hundreds of studies across dozens of diseases… The current medical system… doctors, students, and health care practitioners in general have become so caught up in themselves and their ignorance they’ve lost sight of the goal… to solve broken biology Wake up!! Comment “FOREVER” for research Never miss Dr Trevor Bachmeyer The Spartan #health #longevity #doctor #nevermiss #thespartan Medical Disclaimer: The contents of this video & other material are intended for entertainment, informational & educational purposes only & not for the purpose of rendering medical advice, always seek the advice of a health professional

Show less
Video transcriptshow

BPC-157 forever? Yeah. 2018, Sekerik proved that low, long-term, consistent daily dosing creates a biology that prevents damage and disease from happening far better than high-dose cycling. We're talking micrograms, not milligrams, creates something called biological memory. Your cells remember how to resolve inflammation. The immune system recalibrates. Endothelial cells crank up healing. Here's

Show full video transcript

the physiology. When you hold a consistent low dose, you're stabilizing regulatory T cell population, Tregs, the immune cells that tell your immune system when to stop fighting. Chronically inflamed people have depleted Treg populations. Their immune system forgot how to call off the attack. BPC-157 restores that population. But here's the second order effect, and this is awesome. As Treg populations expand, regulatory dendritic cells expand too. These are immune cells that actively suppress inflammatory response and generate tolerogenic responses. So you're not just suppressing inflammation. response and generate tolerogenic responses. So you're not just suppressing inflammation, you're building a new, more intelligent immune memory that can distinguish between real threats and false alarms. There's even more. Long-term low dose also spools up autophagy, specifically mitophagy, which targets damaged mitochondria. So the old damaged mitochondria are being removed and new healthy ones are being generated. So ATP production isn't just stabilized, it's improved. And here's the systemic benefit. As mitochondrial quality improves, listen to this, NAD plus levels improve because NAD plus is produced in healthy mitochondria and consumed in damaged ones. So when NAD plus improves, sirtuins activate. These are like longevity genes. They activate autophagy, metophagy, DNA repair, circadian rhythm regulation. It also causes fibroblasts, the cells that produce collagen and create the structural integrity of every single tissue that you've got. They don't just temporarily increase their production. They upregulate growth factor receptors. The simple explanation is biology becomes better at healing, period. 2009, NIH proved that long-term BPC-157 causes persistent improvements in tissue repair capacity and structural improvement across your entire system. When you're injured or chronically stressed like everybody is right now, your body needs to create new blood vessels to supply oxygen to damaged tissues. 2013 Tisley R proved BPC-157 doesn't just encourage this process, it optimizes it. And here's the rub. Long-term dosing also improves your ability to create new neurons. It increases BDNF, brain-derived neurotrophic factors. So you're not just healing tissue, you're enhancing your nervous system's plasticity. They also proved it creates sharper cognition long-term. Over 15 years of research, hundreds and hundreds of studies across dozens of diseases, there is no evidence of BPC-157 toxicity, organ damage, or cancer promotion whatsoever. What it has proven is consistent biological improvement across every single measure. Comment forever for the research. I've got to go. Never miss.

Show less

Claim Breakdown(6 claims found)

1

Low, long-term, consistent, daily dosing of BPC-157 prevents damage and disease better than high-dose cycling.

Creator cited:2018, SekerikStudy doesn't support this
What the study actually says: No valid study found for 'Sekerik 2018'. Likely a fabricated or misrepresented citation.
No Evidence

No PubMed studies found to support the specific claim about low, long-term, consistent, daily dosing of BPC-157 preventing damage better than high-dose cycling.

2

Low dose BPC-157 dosing creates biological memory, where cells remember how to resolve inflammation leading to immune system recalibration.

No Evidence

No scientific evidence found supporting the claim that low-dose BPC-157 creates a biological memory for inflammation resolution.

3

BPC-157 restores Treg populations, which are depleted in chronically inflamed individuals.

No Evidence

No PubMed studies found demonstrating BPC-157's specific effect on Treg population restoration.

4

Long-term low-dose BPC-157 enhances autophagy and mitophagy, removing damaged mitochondria and improving ATP production and NAD+ levels, which activate sirtuins.

No Evidence

No scientific studies found supporting the claim about BPC-157's long-term effects on autophagy, mitophagy, ATP production, and NAD+ levels.

5

Long-term BPC-157 causes persistent improvements in tissue repair capacity and structural improvement across the entire system.

Creator cited:2009, NIHStudy doesn't support this
What the study actually says: No valid '2009 NIH' study found to support this claim.
No Evidence

No PubMed studies found to validate the claim of long-term BPC-157 causing persistent improvements in tissue repair capacity.

6

Long-term BPC-157 improves the ability to create new neurons, increases BDNF, and enhances nervous system plasticity and cognition.

Creator cited:2013 Tisley RStudy doesn't support this
What the study actually says: No valid '2013 Tisley R' study identified in PubMed searches.
No Evidence

No scientific evidence found supporting claims about BPC-157's long-term effects on neurogenesis, BDNF, and cognitive enhancement.

Share this audit

Preview post text
❌ AI fact-checked @Dr Trevor Bachmeyer's peptide claims:

Verdict: NO EVIDENCE
This set of claims about BPC-157 appears to be entirely unsupported by scientific literature. No Pub…
6 claims checked vs PubMed.

Full breakdown 👇
https://peptiq.io/check/4580f0f6-6b56-44cf-a0f0-e70c6e570d0a

@peptiq.io #PeptideScience #Biohacking
https://peptiq.io/check/4580f0f6-6b56-44cf-a0f0-e70c6e570d0a

Audit another post

3 free per day, no account needed

New audit

Track your peptide protocols

Download the PeptIQ app for dosing, logging, and more

Get the app

This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.

Report an error